Nebenwirkungen · NovoMix
NovoMix 30 Penfill 100 units/ml suspension for injection in cartridge NovoMix 30 FlexPen 100 units/ml suspension for injection in pre-filled pen · Abschnitt 4.8 · PDF-Seite 7
HOS-091219 · Präparat HOS-084239
At the beginning of the insulin treatment, refraction anomalies, oedema and injection site reactions (pain, redness, hives, inflammation, bruising, swelling and itching at the injection site) may occur. These reactions are usually of a transitory nature. Fast improvement in blood glucose control may be associated with acute painful neuropathy, which is usually reversible. Intensification of insulin therapy with abrupt improvement in glycaemic control may be associated with temporary worsening of diabetic retinopathy, while long-term improved glycaemic control decreases the risk of progression of diabetic retinopathy.
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2023-08-29T13:39:00Z · SHA-256 a9b6af8deb9323a5e47af7edaf7c4d716632fe6a60c5ba5c930ab9830ed01a03 · Passage 43bf1d5e3dce452b353a7adcf0ab3e439ffecaec389091f057f0ef1b1ad2a099 · Zeichen 400–1024 im Abschnitt